Fejős Ida, Varga Erzsébet, Benkovics Gábor, Darcsi András, Malanga Milo, Fenyvesi Éva, Sohajda Tamás, Szente Lajos, Béni Szabolcs
Department of Pharmacognosy, Semmelweis University, Budapest, H-1085 Üllői út 26, Hungary.
CycloLab, Cyclodextrin R&D Ltd, Budapest, H-1097 Illatos út 7, Hungary.
J Chromatogr A. 2016 Oct 7;1467:454-462. doi: 10.1016/j.chroma.2016.07.033. Epub 2016 Jul 15.
The enantioselectivity of neutral single-isomer synthetic precursors of sulfated-β-cyclodextrins was studied. Four neutral single-isomer cyclodextrins substituted on the secondary side with acetyl and/or methyl functional groups, heptakis(2-O-methyl-3,6-dihydroxy)-β-cyclodextrin (HM-β-CD), heptakis(2,3-di-O-acetyl-6-hydroxy)-β-cyclodextrin (HDA-β-CD), heptakis(2,3-di-O-methyl-6-hydroxy)-β-cyclodextrin (HDM-β-CD), heptakis(2-O-methyl-3-O-acetyl-6-hydroxy)-β-cyclodextrin (HMA-β-CD), and their sulfated analogs the negatively charged heptakis(2,3-di-O-methyl-6-sulfato)-β-cyclodextrin (HDMS-β-CD) and heptakis(2,3-di-O-acetyl-6-sulfato)-β-cyclodextrin (HDAS-β-CD) were investigated by non-aqueous capillary electrophoresis in the view of enantiodiscrimination for various drugs and related pharmaceutical compounds. The focus of the present work was on the chiral selectivity studies of the neutral derivatives, which are the synthesis intermediates of the sulfated products. The chiral recognition experiments proved that among the neutral compounds the HMA-β-CD shows remarkable enantioselectivity towards chiral guests in non-aqueous capillary electrophoresis, while HM-β-CD, HDA-β-CD and HDM-β-CD failed to resolve any of the 25 studied racemates under the applied experimental conditions. In order to get deeper insight into the molecular interactions between the studied single-isomer cyclodextrin and chiral fluoroquinolones (ofloxacin, gatifloxacin and lomefloxacin) and β-blockers (propranolol), H and ROESY NMR experiments were performed. The 2-O-methylation in combination with the 3-O-acetylation of the host was evidenced to exclusively carry the essential spatial arrangement for chiral recognition.
研究了硫酸化β-环糊精中性单异构体合成前体的对映选择性。研究了四种在仲位被乙酰基和/或甲基官能团取代的中性单异构体环糊精,七(2-O-甲基-3,6-二羟基)-β-环糊精(HM-β-CD)、七(2,3-二-O-乙酰基-6-羟基)-β-环糊精(HDA-β-CD)、七(2,3-二-O-甲基-6-羟基)-β-环糊精(HDM-β-CD)、七(2-O-甲基-3-O-乙酰基-6-羟基)-β-环糊精(HMA-β-CD),以及它们的硫酸化类似物,带负电荷的七(2,3-二-O-甲基-6-硫酸根)-β-环糊精(HDMS-β-CD)和七(2,3-二-O-乙酰基-6-硫酸根)-β-环糊精(HDAS-β-CD),通过非水毛细管电泳研究了它们对各种药物及相关药物化合物的对映体识别能力。本研究的重点是对作为硫酸化产物合成中间体的中性衍生物的手性选择性研究。手性识别实验证明,在非水毛细管电泳中,在中性化合物中HMA-β-CD对手性客体表现出显著的对映选择性,而在应用的实验条件下,HM-β-CD、HDA-β-CD和HDM-β-CD未能拆分所研究的25种外消旋体中的任何一种。为了更深入地了解所研究的单异构体环糊精与手性氟喹诺酮类药物(氧氟沙星、加替沙星和洛美沙星)以及β-受体阻滞剂(普萘洛尔)之间的分子相互作用,进行了H和ROESY NMR实验。结果表明,主体的2-O-甲基化与3-O-乙酰化相结合专门携带了手性识别所需的空间排列。